Your browser doesn't support javascript.
loading
Mutational landscape of gray zone lymphoma.
Sarkozy, Clémentine; Hung, Stacy S; Chavez, Elizabeth A; Duns, Gerben; Takata, Katsuyoshi; Chong, Lauren C; Aoki, Tomohiro; Jiang, Aixiang; Miyata-Takata, Tomoko; Telenius, Adèle; Slack, Graham W; Molina, Thierry Jo; Ben-Neriah, Susana; Farinha, Pedro; Dartigues, Peggy; Damotte, Diane; Mottok, Anja; Salles, Gilles A; Casasnovas, Rene-Olivier; Savage, Kerry J; Laurent, Camille; Scott, David W; Traverse-Glehen, Alexandra; Steidl, Christian.
Afiliação
  • Sarkozy C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Hung SS; INSERM Unité Mixte de Recherche (UMR) S1052, Centre National de la Recherche UMR 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Chavez EA; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Duns G; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Takata K; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Chong LC; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Aoki T; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Jiang A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Miyata-Takata T; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Slack GW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Molina TJ; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Ben-Neriah S; Pathology Department, Necker Enfants Malades Hospital, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Farinha P; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Dartigues P; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Damotte D; Pathology Department, Gustave Roussy, Université Paris-Saclay, INSERM U1170, Villejuif, France.
  • Mottok A; Pathology Department, Groupe Hospitalier Cochin, AP-HP, Paris, France.
  • Salles GA; INSERM U1138, Paris Descartes University-Sorbonne Paris Cité, Paris, France.
  • Casasnovas RO; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Savage KJ; INSERM Unité Mixte de Recherche (UMR) S1052, Centre National de la Recherche UMR 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
  • Laurent C; Département d'Hématologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Bénite Cedex, France.
  • Scott DW; Department of Hematology, François Mitterrand University Hospital, INSERM U1231, Dijon, France.
  • Traverse-Glehen A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.
  • Steidl C; Institut Universitaire du Cancer-Oncopole de Toulouse, CHU Toulouse, INSERM U1037, Centre de Recherche en Cancerologie de Toulouse-Purpan, Toulouse-Purpan, France; and.
Blood ; 137(13): 1765-1776, 2021 04 01.
Article em En | MEDLINE | ID: mdl-32961552
The mutational landscape of gray zone lymphoma (GZL) has not yet been established, and differences from related entities are largely unknown. Here, we studied coding sequence mutations of 50 Epstein-Barr virus (EBV)-negative GZLs and 20 polymorphic EBV+ diffuse large B-cell lymphoma (DLBCL) not otherwise specified (poly-EBV-L) in comparison with classical Hodgkin lymphoma (cHL), primary mediastinal large B-cell lymphoma (PMBCL), and DLBCL. Exomes of 21 GZL and 7 poly-EBV-L cases, along with paired constitutional DNA, were analyzed as a discovery cohort, followed by targeted sequencing of 217 genes in an extension cohort of 29 GZL and 13 poly-EBV-L cases. GZL cases with thymic niche involvement (anterior mediastinal mass) exhibited a mutation profile closely resembling cHL and PMBCL, with SOCS1 (45%), B2M (45%), TNFAIP3 (35%), GNA13 (35%), LRRN3 (32%), and NFKBIA (29%) being the most recurrently mutated genes. In contrast, GZL cases without thymic niche involvement (n = 18) had a significantly distinct pattern that was enriched in mutations related to apoptosis defects (TP53 [39%], BCL2 [28%], BIRC6 [22%]) and depleted in GNA13, XPO1, or NF-κB signaling pathway mutations (TNFAIP3, NFKBIE, IKBKB, NFKBIA). They also exhibited more BCL2/BCL6 rearrangements compared with thymic GZL. Poly-EBV-L cases presented a distinct mutational profile, including STAT3 mutations and a significantly lower coding mutation load in comparison with EBV- GZL. Our study highlights characteristic mutational patterns in GZL associated with presentation in the thymic niche, suggesting a common cell of origin and disease evolution overlapping with related anterior mediastinal lymphomas.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Difuso de Grandes Células B / Neoplasias do Mediastino / Mutação Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Linfoma Difuso de Grandes Células B / Neoplasias do Mediastino / Mutação Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá